Tscan Therapeutics Inc (TCRX) — Financial Flexibility Index
Tscan Therapeutics Inc (TCRX) has a Financial Flexibility Index of -0.26x as of June 2026. Free cash flow of $-27.04 Million (operating CF $-27.54 Million minus capex $493.00K) represents 0% of total liabilities ($102.43 Million). Check TCRX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tscan Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Tscan Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see TCRX cash generation efficiency.
Annual Financial Flexibility Index for Tscan Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Tscan Therapeutics Inc. Explore TCRX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.24x | $-130.91 Million | $-135.32 Million | $105.67 Million | ▼ -50.7% |
| 2024 | -0.82x | $-107.00 Million | $-110.82 Million | $130.15 Million | ▼ -71.3% |
| 2023 | -0.48x | $-58.21 Million | $-61.36 Million | $121.28 Million | ▲ +23.2% |
| 2022 | -0.62x | $-62.28 Million | $-66.50 Million | $99.66 Million | ▲ +55.9% |
| 2021 | -1.42x | $-38.74 Million | $-48.68 Million | $27.33 Million | ▼ -10855.9% |
| 2020 | 0.01x | $1.22 Million | $-3.02 Million | $92.20 Million | ▲ +100.8% |
| 2019 | -1.65x | $-11.28 Million | $-12.52 Million | $6.84 Million | — |